Ron Wyden
DemocratSenate
Track 6 stock and financial transactions disclosed by Ron Wyden, including assets, buys, sells, filing dates, and reported value ranges.
Total Trades
6
Trade Volume
$349,003
Last Traded
Jun 3, 2025
Last four quarters; counted by reported trade date.
Top four sectors; rest grouped under Other sectors.
Trading History
| Asset | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| PFEPfizer Inc. | Jul 2, 2025 | Jun 3, 2025 | Sell | $1,001 - $15,000 | +28.48% |
| LLYEli Lilly & Co. | Feb 21, 2025 | Feb 10, 2025 | Sell | $50,001 - $100,000 | +62.21% |
| SOLVSolventum Corporation | Feb 21, 2025 | Feb 6, 2025 | Sell | $1,001 - $15,000 | +13.35% |
| LLYEli Lilly & Co. | Feb 21, 2025 | Jan 22, 2025 | Buy | $50,001 - $100,000 | +86.93% |
Ron Wyden has disclosed 6 trades: 1 purchases and 4 sales, with an estimated volume of $349,003 based on the midpoint of each reported range. The most recent trade was on Jun 3, 2025.
Ron Wyden's most recent disclosed stock purchase was Eli Lilly & Co. (LLY) on Jan 22, 2025, valued at $50,001 - $100,000.
Ron Wyden's most recent disclosed stock sale was Pfizer Inc. (PFE) on Jun 3, 2025, valued at $1,001 - $15,000.
By number of disclosed trades: LLY (2), PFE (1), SOLV (1).
From Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.